跳至主要内容
临床试验/NCT01722409
NCT01722409已完成4 期

Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization

China Medical University, China1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
64
试验地点
1
主要终点
Observing the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.

研究概览

简要总结

The investigators designed a double-blind, randomized placebo-controlled study to determine the effects of dexmedetomidine on the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-65 years old ASA I or ASA II patients undergoing ECE treatment for intracranial aneurysms were included.

排除标准

  • Patients were excluded based on the following parameters: older than 65 yrs, a history of mental illness, recent use of sedatives or analgesics and with sensation.

研究组 & 干预措施

sevoflurane and 0.5 μg/kg dexmedetomidine

Experimental

After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes.

干预措施: sevoflurane and 0.5 μg/kg dexmedetomidine (Drug)

sevoflurane and 1 μg/kg dexmedetomidine

Experimental

After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes.

干预措施: sevoflurane and 1 μg/kg dexmedetomidine (Drug)

结局指标

主要结局

Observing the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.

时间窗: At the end of the operation and 24 hours later

The time from termination of the general anesthetic to the time that the patient's eyes opened. Anesthesiologists collected information on emergence agitation, postoperative nausea and vomiting for 24 hours after the surgery.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wen-fei Tan

Associate professor

China Medical University, China

研究点 (1)

Loading locations...

相似试验